School of Medicine
Showing 1-10 of 15 Results
-
Ramon Luis Ramirez
Affiliate, Dean's Office Operations - Dean Other
BioUndergraduate: University of Texas at San Antonio
Medical Education: University of Texas Southwestern Medical School at Dallas
Residency: Stanford Health Care-Sponsored Stanford University Program
Fellowship: Stanford Health Care-Sponsored Stanford University Program
Recent Publications:
Ramirez RL, Perez VDJ, Zamanian RT. Methamphetamine and the risk of pulmonary arterial hypertension. Current Opinion in Pulmonary Medicine. 2018;24(5):416-424. doi:10.1097/mcp.0000000000000513.
Ramon L. Ramirez III, Vinicio De Jesus Perez, and Roham T. Zamanian (2018) Stimulants and Pulmonary Arterial Hypertension: An Update. Advances in Pulmonary Hypertension: 2018, Vol. 17, No. 2, pp. 49-54.
Ramirez III RL, Thomas CA, Anderson RJ, Bernardo RJ, Al-Motarreb A,
Al-Suwaidi J, Zamanian RT, de Jesus Perez VA. Drug- and toxin-induced pulmonary arterial hypertension: Current state of the literature. Global Cardiology Science and Practice 2019:19 https://doi.org/10.21542/gcsp.2019.19 -
Agnes Reschke
Affiliate, Dean's Office Operations - Dean Other
Fellow in Pediatrics - Hematology & OncologyBioAgnes Reschke, MD is a clinical fellow in the Division of Pediatric Hematology and Oncology at the Lucile Packard Children's Hospital, Stanford University School of Medicine. She obtained her bachelor of science and honors from Villanova University and after her family moved to Kentucky, went on to medical school at University of Kentucky College of Medicine. She completed a pediatric residency at Connecticut Children's Medical Center and during that time, focused on a clinical research project evaluating a proposed association between domestic radon levels and the development of sarcoma. Dr. Reschke ultimately came to Lucile Packard Children's Hospital for her pediatric hematology/oncology fellowship and during that time, discovered the emerging field of onco-critical care. Her fellowship research is in the lab of Tim Cornell, chief of pediatric critical care at Stanford. She is working to apply a real-time assay to measure cytokines in subsets of pediatric oncology patients to guide immunomodulatory therapies. By gaining a better understanding of these patients’ immune responses in real time, she believes that we will open the door for precision immunomodulatory therapy to treat critically ill patients, especially those experiencing sepsis or cytokine release syndrome. After completion of her hematology/oncology fellowship, Dr. Reschke will be pursuing a pediatric intensive care fellowship with the hope of becoming a leader and pioneer in onco-critical care.
-
Rochelle Reyes
E4C PA, Physician Assistant Studies
BioRochelle Reyes is an advance practice provider with more than 10 years of Oncology practice. She currently specializes in and leads the genomics program at Stanford Health care with Dr Ford.
